These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 22704017

  • 1. Late adverse effects of the coadministration of valproate and lamotrigine.
    Thome-Souza S, Moreira B, Valente KD.
    Pediatr Neurol; 2012 Jul; 47(1):47-50. PubMed ID: 22704017
    [Abstract] [Full Text] [Related]

  • 2. Valproate and lamotrigine in pediatric patients with refractory epilepsy: after the first year.
    Thome-Souza S, Valente KD.
    Pediatr Neurol; 2013 Jun; 48(6):436-42. PubMed ID: 23668867
    [Abstract] [Full Text] [Related]

  • 3. Lamotrigine and valproate: efficacy of co-administration in a pediatric population.
    Thomé-Souza S, Freitas A, Fiore LA, Valente KD.
    Pediatr Neurol; 2003 May; 28(5):360-4. PubMed ID: 12878297
    [Abstract] [Full Text] [Related]

  • 4. Plasma free carnitine in epilepsy children, adolescents and young adults treated with old and new antiepileptic drugs with or without ketogenic diet.
    Coppola G, Epifanio G, Auricchio G, Federico RR, Resicato G, Pascotto A.
    Brain Dev; 2006 Jul; 28(6):358-65. PubMed ID: 16376041
    [Abstract] [Full Text] [Related]

  • 5. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
    Zeng K, Wang X, Xi Z, Yan Y.
    Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
    [Abstract] [Full Text] [Related]

  • 6. Telogen effluvium caused by magnesium valproate and lamotrigine.
    Patrizi A, Savoia F, Negosanti F, Posar A, Santucci M, Neri I.
    Acta Derm Venereol; 2005 May; 85(1):77-8. PubMed ID: 15849002
    [No Abstract] [Full Text] [Related]

  • 7. Vulnerability of an epileptic case to psychosis: sodium valproate with lamotrigine, forced normalization, postictal psychosis or all?
    Turan AB, Seferoglu M, Taskapilioglu O, Bora I.
    Neurol Sci; 2012 Oct; 33(5):1161-3. PubMed ID: 22131039
    [Abstract] [Full Text] [Related]

  • 8. Valproate as a risk factor for lamotrigine discontinuation.
    Abe Y, Yasugawa S, Miyamoto K, Terao T.
    J Affect Disord; 2013 Sep 25; 150(3):1197-9. PubMed ID: 23747209
    [Abstract] [Full Text] [Related]

  • 9. Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy.
    Baumann RJ, Fakhoury TA, Kustra RP, Vuong A, Hammer AE, Messenheimer JA.
    Curr Med Res Opin; 2007 Oct 25; 23(10):2461-5. PubMed ID: 17727739
    [Abstract] [Full Text] [Related]

  • 10. Long-term control of epileptic drop attacks with the combination of valproate, lamotrigine, and a benzodiazepine: a 'proof of concept,' open label study.
    Machado VH, Palmini A, Bastos FA, Rotert R.
    Epilepsia; 2011 Jul 25; 52(7):1303-10. PubMed ID: 21729037
    [Abstract] [Full Text] [Related]

  • 11. Phenobarbital/Lamotrigine coadministration-induced blood dyscrasia in a patient with epilepsy.
    Siniscalchi A, Gallelli L, Calabrò G, Tolotta GA, De Sarro G.
    Ann Pharmacother; 2010 Dec 25; 44(12):2031-4. PubMed ID: 21098752
    [Abstract] [Full Text] [Related]

  • 12. A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy.
    Sale ME, Natarajan S, Biton V, Vuong A, Hammer AE, Messenheimer JA, Blum D.
    Epilepsy Behav; 2005 Feb 25; 6(1):63-70. PubMed ID: 15652736
    [Abstract] [Full Text] [Related]

  • 13. Worsening of negative myoclonus by lamotrigine in a case of idiopathic focal epilepsy of children with long-term follow-up.
    Gélisse P, Genton P, Velizarova R, Serafini A, Crespel A.
    Brain Dev; 2012 Mar 25; 34(3):248-50. PubMed ID: 21621357
    [Abstract] [Full Text] [Related]

  • 14. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability.
    Alvarez N, Besag F, Iivanainen M.
    J Intellect Disabil Res; 1998 Dec 25; 42 Suppl 1():1-15. PubMed ID: 10030426
    [Abstract] [Full Text] [Related]

  • 15. Toxic epidermal necrolysis with combination lamotrigine and valproate in bipolar disorder.
    Chang CC, Shiah IS, Chang HA, Huang SY.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan 25; 30(1):147-50. PubMed ID: 16225978
    [Abstract] [Full Text] [Related]

  • 16. Reversible valproate-induced choreiform movements.
    Gunal DI, Guleryuz M, Bingol CA.
    Seizure; 2002 Apr 25; 11(3):205-6. PubMed ID: 12018966
    [Abstract] [Full Text] [Related]

  • 17. Bidirectional interaction of valproate and lamotrigine in healthy subjects.
    Anderson GD, Yau MK, Gidal BE, Harris SJ, Levy RH, Lai AA, Wolf KB, Wargin WA, Dren AT.
    Clin Pharmacol Ther; 1996 Aug 25; 60(2):145-56. PubMed ID: 8823232
    [Abstract] [Full Text] [Related]

  • 18. Long-term effectiveness of ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.
    Hwang H, Kim H, Kim SH, Kim SH, Lim BC, Chae JH, Choi JE, Kim KJ, Hwang YS.
    Brain Dev; 2012 May 25; 34(5):344-8. PubMed ID: 21893390
    [Abstract] [Full Text] [Related]

  • 19. Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.
    Moeller JJ, Rahey SR, Sadler RM.
    Epilepsia; 2009 Mar 25; 50(3):475-9. PubMed ID: 19054403
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of renal tubular function in children taking anti-epileptic treatment.
    Unay B, Akin R, Sarici SU, Gok F, Kurt I, Gokcay E.
    Nephrology (Carlton); 2006 Dec 25; 11(6):485-8. PubMed ID: 17199783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.